Kelley Robert J. 4
4 · Talis Biomedical Corp · Filed Jun 2, 2022
Insider Transaction Report
Form 4
Kelley Robert J.
Chief Commercial Officer
Transactions
- Award
Stock Option (right to buy)
2022-06-01+723,560→ 723,560 totalExercise: $1.03Exp: 2032-05-31→ Common Stock (723,560 underlying)
Footnotes (3)
- [F1]1/3 of awards vest as follows: 25% of the shares underlying this option shall vest on the first annual anniversary of the vesting commencement date of June 1, 2022 (VCD) and 1/48th of the shares underlying this option shall vest monthly thereafter over 36 months.
- [F2]1/3 of the shares shall vest on the seventh anniversary of the VCD, subject to optionholder's continuous service as of such date, provided that such vesting shall be subject to acceleration based upon certain pre-determined commercial and regulatory milestones.
- [F3]1/3 of the shares shall vest on the seventh anniversary of the VCD, subject to optionholder's continuous service as of such date, provided that such vesting shall be subject to partial or full acceleration based on pre-determined closing prices of the Company's common stock sustained for a certain number of consecutive trading days.